Thyrocare Technologies Ltd.
BSE: 539871 | Sector: Health care |
NSE: THYROCARE | ISIN Code: INE594H01019 |
BSE 00:00 | 24 Feb | 913.90 |
-9.65 (-1.04%) |
OPEN
920.35 |
HIGH
920.35 |
LOW
900.00 |
NSE 00:00 | 24 Feb | 914.70 |
-10.15 (-1.10%) |
OPEN
923.00 |
HIGH
923.00 |
LOW
890.20 |
OPEN | 920.35 |
PREVIOUS CLOSE | 923.55 |
VOLUME | 11031 |
52-Week high | 1212.00 |
52-Week low | 410.00 |
P/E | 47.85 |
Mkt Cap.(Rs cr) | 4,832 |
Buy Price | 913.90 |
Buy Qty | 27.00 |
Sell Price | 917.00 |
Sell Qty | 26.00 |
Thyrocare Technologies Ltd. (THYROCARE) - Market Capital
Market Cap
COMPANY | LATEST(Rs) | CHG(%) | 52 Wk High | 52 Wk Low | MKT-CAP (RS CR) |
Sun Pharma.Inds. | 602.55 | -0.25 | 653.70 | 315.20 | 144569.82 |
Divi's Lab. | 3483.10 | 0.98 | 3913.00 | 1632.70 | 92458.89 |
Dr Reddy's Labs | 4441.50 | -1.06 | 5514.65 | 2497.60 | 73862.15 |
Cipla | 789.55 | -0.17 | 878.55 | 356.75 | 63673.26 |
Aurobindo Pharma | 862.15 | 0.72 | 1023.10 | 281.15 | 50513.37 |
Biocon | 389.90 | 1.18 | 487.70 | 235.80 | 46788.00 |
Lupin | 1007.60 | -0.30 | 1121.85 | 505.00 | 45704.74 |
Cadila Health. | 433.90 | 0.81 | 509.35 | 212.70 | 44418.34 |
Apollo Hospitals | 3058.25 | 2.03 | 3283.90 | 1047.45 | 43971.52 |
Piramal Enterp. | 1858.80 | 0.44 | 1931.45 | 608.00 | 41925.23 |
Torrent Pharma. | 2476.35 | 2.09 | 3040.00 | 1619.00 | 41904.80 |
Gland Pharma | 2367.10 | -0.60 | 2509.05 | 1701.00 | 38702.09 |
Alkem Lab | 2765.40 | 1.46 | 3150.00 | 1950.00 | 33060.36 |
Abbott India | 14582.40 | 0.74 | 18569.00 | 12500.00 | 30987.60 |
Glaxosmi. Pharma | 1455.30 | 0.12 | 1805.00 | 1046.40 | 24654.24 |
Ipca Labs. | 1868.00 | 3.67 | 2455.55 | 1162.00 | 23695.58 |
Syngene Intl. | 569.05 | 1.51 | 644.65 | 201.65 | 22762.00 |
Pfizer | 4484.55 | 0.64 | 5875.00 | 3588.15 | 20516.82 |
Laurus Labs | 359.80 | -0.37 | 385.80 | 61.90 | 19306.87 |
Dr Lal Pathlabs | 2288.80 | 0.14 | 2626.30 | 1181.80 | 19074.86 |
Quick Links for Thyrocare Technologies:
-
News
Announcements Brokerage Reports Business Earnings Sector -
Corporate Action
AGM Board Meetings Bonus Dividends EGM Rights Split -
INFORMATION
Bulk Deals Company History MF Holding Listing Info Locations Shareholding -
Financials
Financial Overview Balance Sheet Profit & Loss Cash Flow Ratios Quarterly Results Half Yearly Results Nine Monthly Results Yearly Results -
Annual Report
Auditors Report Chairman's Speech Company Management Directors' Report Finished Goods Raw Materials -
Peer Comparison
Competition Market Cap Price Price Performance Net Sales Net Profit Total Assets Historical Prices